Form 8-K - Current report:
SEC Accession No. 0001193125-26-249790
Filing Date
2026-06-01
Accepted
2026-06-01 08:07:23
Documents
56
Period of Report
2026-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d19106d8k.htm   iXBRL 8-K 76626
2 EX-2.1 d19106dex21.htm EX-2.1 687630
3 EX-10.1 d19106dex101.htm EX-10.1 52732
4 EX-10.2 d19106dex102.htm EX-10.2 82398
5 EX-10.3 d19106dex103.htm EX-10.3 31370
6 EX-10.4 d19106dex104.htm EX-10.4 93874
7 EX-10.5 d19106dex105.htm EX-10.5 146562
8 EX-10.6 d19106dex106.htm EX-10.6 128229
9 EX-10.7 d19106dex107.htm EX-10.7 8310
10 EX-10.8 d19106dex108.htm EX-10.8 8235
11 EX-10.9 d19106dex109.htm EX-10.9 8922
12 EX-99.1 d19106dex991.htm EX-99.1 33346
13 EX-99.2 d19106dex992.htm EX-99.2 48615
14 EX-99.3 d19106dex993.htm EX-99.3 15447
18 GRAPHIC g19106dsp261a.jpg GRAPHIC 5396
19 GRAPHIC g19106dsp261b.jpg GRAPHIC 7830
20 GRAPHIC g19106ex99_2p10g1.jpg GRAPHIC 421416
21 GRAPHIC g19106ex99_2p11g1.jpg GRAPHIC 365885
22 GRAPHIC g19106ex99_2p12g1.jpg GRAPHIC 460892
23 GRAPHIC g19106ex99_2p13g1.jpg GRAPHIC 381523
24 GRAPHIC g19106ex99_2p14g1.jpg GRAPHIC 324319
25 GRAPHIC g19106ex99_2p15g1.jpg GRAPHIC 283341
26 GRAPHIC g19106ex99_2p16g1.jpg GRAPHIC 364148
27 GRAPHIC g19106ex99_2p17g1.jpg GRAPHIC 344302
28 GRAPHIC g19106ex99_2p18g1.jpg GRAPHIC 359929
29 GRAPHIC g19106ex99_2p19g1.jpg GRAPHIC 283127
30 GRAPHIC g19106ex99_2p1g1.jpg GRAPHIC 175099
31 GRAPHIC g19106ex99_2p20g1.jpg GRAPHIC 291963
32 GRAPHIC g19106ex99_2p21g1.jpg GRAPHIC 312392
33 GRAPHIC g19106ex99_2p22g1.jpg GRAPHIC 340585
34 GRAPHIC g19106ex99_2p23g1.jpg GRAPHIC 378840
35 GRAPHIC g19106ex99_2p24g1.jpg GRAPHIC 477411
36 GRAPHIC g19106ex99_2p25g1.jpg GRAPHIC 404440
37 GRAPHIC g19106ex99_2p26g1.jpg GRAPHIC 352160
38 GRAPHIC g19106ex99_2p27g1.jpg GRAPHIC 262122
39 GRAPHIC g19106ex99_2p28g1.jpg GRAPHIC 314822
40 GRAPHIC g19106ex99_2p29g1.jpg GRAPHIC 297498
41 GRAPHIC g19106ex99_2p2g1.jpg GRAPHIC 594657
42 GRAPHIC g19106ex99_2p30g1.jpg GRAPHIC 572041
43 GRAPHIC g19106ex99_2p3g1.jpg GRAPHIC 424034
44 GRAPHIC g19106ex99_2p4g1.jpg GRAPHIC 239216
45 GRAPHIC g19106ex99_2p5g1.jpg GRAPHIC 428109
46 GRAPHIC g19106ex99_2p6g1.jpg GRAPHIC 277936
47 GRAPHIC g19106ex99_2p7g1.jpg GRAPHIC 323277
48 GRAPHIC g19106ex99_2p8g1.jpg GRAPHIC 309671
49 GRAPHIC g19106ex99_2p9g1.jpg GRAPHIC 403298
  Complete submission text file 0001193125-26-249790.txt   16757593

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA rlyb-20260531.xsd EX-101.SCH 3167
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE rlyb-20260531_lab.xml EX-101.LAB 17975
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rlyb-20260531_pre.xml EX-101.PRE 11249
60 EXTRACTED XBRL INSTANCE DOCUMENT d19106d8k_htm.xml XML 3692
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

EIN.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40693 | Film No.: 261047288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)